A. Score plot of PLS-DA analysis of healthy controls (H), mild/moderate (M), and severe (S) patients. B. Variable importance in the projection (VIP) values that better explain the differences between the groups; C. Enriched metabolite data sets (p<0.05) for the VIP metabolites involved in COVID-19 severity clustering.</p
(A) Main demographic and clinical characteristics of the subjects. (B-C) Values of Log2 fold change ...
IntroductionSince the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics st...
INTRODUCTION Since the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics s...
(A) Proximity plots of the RF model discriminating COVID-19 patients (mild light red dots, severe re...
(A) Main demographic and clinical characteristics of the enrolled subjects (right panel); for each g...
A. Heatmap and hierarchical clustering analysis of COVID-19 and control individuals with all the met...
(A) Partial-least discriminant analysis (PLS-DA) score plot. (B) Variable importance in projection (...
Box plots of the concentration levels for (A) metabolites and (B) lipoprotein parameters (main param...
Saliva metabolomics analysis for COVID-19 diagnosis and prognosis via LC-MS in positive mode, showin...
Box plots of (A) mannose and (B) glucose concentration levels in COVID-19 positive subjects grouped ...
IntroductionThe diagnosis of COVID-19 is normally based on the qualitative detection of viral nuclei...
The data contain all the baseline information about participants in the study (COVID-19 patients an...
Results of subgroup analysis of PCT for predicting mortality and severity in COVID-19 patients.</p
Introduction: The variation in human blood serum metabolites resulting from an infection can assist ...
<p>Partial Least Squares – Discriminant Analysis (PLS-DA) analysis indicates a fair discrimination b...
(A) Main demographic and clinical characteristics of the subjects. (B-C) Values of Log2 fold change ...
IntroductionSince the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics st...
INTRODUCTION Since the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics s...
(A) Proximity plots of the RF model discriminating COVID-19 patients (mild light red dots, severe re...
(A) Main demographic and clinical characteristics of the enrolled subjects (right panel); for each g...
A. Heatmap and hierarchical clustering analysis of COVID-19 and control individuals with all the met...
(A) Partial-least discriminant analysis (PLS-DA) score plot. (B) Variable importance in projection (...
Box plots of the concentration levels for (A) metabolites and (B) lipoprotein parameters (main param...
Saliva metabolomics analysis for COVID-19 diagnosis and prognosis via LC-MS in positive mode, showin...
Box plots of (A) mannose and (B) glucose concentration levels in COVID-19 positive subjects grouped ...
IntroductionThe diagnosis of COVID-19 is normally based on the qualitative detection of viral nuclei...
The data contain all the baseline information about participants in the study (COVID-19 patients an...
Results of subgroup analysis of PCT for predicting mortality and severity in COVID-19 patients.</p
Introduction: The variation in human blood serum metabolites resulting from an infection can assist ...
<p>Partial Least Squares – Discriminant Analysis (PLS-DA) analysis indicates a fair discrimination b...
(A) Main demographic and clinical characteristics of the subjects. (B-C) Values of Log2 fold change ...
IntroductionSince the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics st...
INTRODUCTION Since the beginning of the SARS-CoV-2 pandemic in December 2019 multiple metabolomics s...